FindTrial
Sign In

To check the safety and benefit of Ahaglow Gentle Cleanser for daily use in dry sensitive skin

A Patient Reported Outcome study to Assess Clinical Impact, Safety and Utilization of Cetyl Alcohol, Stearyl alcohol and Oat meal based cleanser for daily use in Dry Sensitive Skin (CASO-DSS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053708
Enrollment
1530
Registered
2023-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Ahaglow Gentle Cleanser (face wash): Apply Ahaglow Gentle Cleanser topically two to three times daily as per prescribed by physician for 2 weeks. Total Duration for 2 Weeks Control Inte

Sponsors

Torrent Pharmaceuticals Ltd,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from Dry Sensitive Skin conditions 2. Clinical cases requiring complementary add on or maintenance therapy.

Exclusion criteria

Exclusion criteria: Hypersensitivity to ingredients of the cleanser Allergic skin conditions other than dry sensitive skin

Design outcomes

Primary

MeasureTime frame
Safety Assessment- Incidence of treatment emergent adverse events (TEAEs) [i.e.Safety and Tolerability] occurring during the course of treatment will be recorded for safety assessment.Timepoint: At 2 week—

Secondary

MeasureTime frame
Patient Global AssessmentTimepoint: at 2 week—

Countries

India

Contacts

Public ContactDr Rathish Nair PhD MBA

Torrent Pharmaceuticals Ltd

krishnaprasadkorukonda@torrentpharma.com7069000572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026